Trex revenues slump in Q2

AuntMinnie.com staff writers
May 4, 2000

The uncertain future of mammography and x-ray has weighed down Trex Medical financial results in the second quarter. For the period ending April 1, the Danbury, CT-based firm had revenues of $41.4 million, down 31.2% compared with the $60.2 million reported in the same quarter in 1999. Trex had a net loss of $6.6 million, compared with a net loss of $4.2 million in 1999. As announced in January, the company continues to look for a buyer. Irresolution among customers and dealers, in light of that announcement, has had a negative impact on the firm, according to William Webb, president and CEO.

By AuntMinnie.com staff writers
May 5, 2000

Copyright © 2000 AuntMinnie.com

Latest in Breast
Breast Mol
FES-PET could save $142M in breast cancer costs
May 20, 2024
Breast Mol
New guidance issued on PET/CT imaging in breast cancer
May 17, 2024
Award-winning research: Screening mammograms showed variable lymph node morphology due to ectopic fat deposition in women with obesity. Image A (above) shows normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with a body mass index (BM) = 43.2. Image B shows a possible fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in a 52-year-old woman with a BMI = 45.8. Photo courtesy of American Roentgen Ray Society.
ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms
May 6, 2024
Breast Cancer3
DBT + CEM boosts cancer detection in women with history of the disease
April 30, 2024
Related Stories
Ge12 17 99 small
Breast
FDA panel votes to recommend GE digital mammo unit
Reuterslogo
Breast
Web-based system may improve mammography screening rates
More in Breast
FES-PET could save $142M in breast cancer costs
By Will Morton
Adding F-18 fluroestradiol (FES)-PET/CT imaging to standard of care tests in women with suspected estrogen receptor-positive breast cancer could save millions.
May 20, 2024
Breast Mol
New guidance issued on PET/CT imaging in breast cancer
By Will Morton
The world’s top nuclear medicine societies have issued international guidelines on the role of PET/CT in patients with invasive ductal carcinoma.
May 17, 2024
Breast Mol
ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms
By Liz Carey
A poster on cardiovascular disease (CVD) risk prediction using fat-enlarged axillary nodes on mammograms won a prestigious award at ARRS 2024.
May 6, 2024
Award-winning research: Screening mammograms showed variable lymph node morphology due to ectopic fat deposition in women with obesity. Image A (above) shows normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with a body mass index (BM) = 43.2. Image B shows a possible fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in a 52-year-old woman with a BMI = 45.8. Photo courtesy of American Roentgen Ray Society.
DBT + CEM boosts cancer detection in women with history of the disease
By Kate Madden Yee
Adding contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) increases early breast cancer detection in women with a history of the disease.
April 30, 2024
Breast Cancer3
USPSTF finalizes breast cancer screening recommendations
By Liz Carey
The USPSTF's final recommendations support breast cancer screening beginning at age 40, but don’t go as far as many screening advocates had hoped.
April 30, 2024
Mammogram Breast
Large language models underperform in breast imaging
By Amerigo Allegretto
Large language models such as ChatGPT and Google Gemini fall short in breast imaging.
April 30, 2024
Screenshot (1152)
U.S. federally qualified health centers show cancer screening gaps
By Kate Madden Yee
U.S. federally qualified health centers, intended to provide care to underserved populations across the country, show cancer screening gaps.
April 29, 2024
Breast Screening Mammo
RadNet teams up with basketball icon Sheryl Swoopes
By AuntMinnie.com staff writers
RadNet has tapped basketball legend and WNBA superstar Sheryl Swoopes as spokesperson for its nationwide breast cancer screening programs.
April 12, 2024
Mammogramnow
AI can be used to 'rule-out' breast cancer on mammography
By Erik L. Ridley
A deep-learning algorithm can rule out the presence of breast cancer on screening mammograms, improving specificity and yielding significant workflow and downstream savings.
April 10, 2024
Artificial Intelligence Ai Binary Code
AI helps select patients for supplemental breast cancer screening
By Erik L. Ridley
An AI-based method can outperform breast density measurements for flagging patients who would benefit from supplemental breast cancer screening.
April 9, 2024
Breast Cancer 3 D
Cryoablation effective in women with breast cancer
By Will Morton
A minimally invasive procedure called cryoablation that uses ice to freeze and destroy tumors has proven effective for women with large breast cancer tumors.
March 27, 2024
Breast Update
FAPI-PET/CT outperforms FDG-PET/CT in women with invasive breast cancer
By Will Morton
PET/CT imaging using gallium-68 FAPI radiotracer over F-18 FDG appears promising in women with invasive lobular carcinoma.
March 15, 2024
Maximum-intensity projection F-18 FDG-PET (left) and Ga-68 FAPI-PET (right) images of synchronous ILC. (A) A 42-year-old patient with multicentric primary lesions (encircled), regional (solid arrows), and distant inferior jugular lymph node (dashed arrows) seen on F-18 FDG-PET and subsequently confirmed on Ga-68 FAPI-PET, which also revealed additional malignant foci aligned with MRI. Some lesions exhibited high activity retention on Ga-68 FAPI-PET. (B) A 53-year-old patient showing no significant uptake on F-18 FDG-PET but synchronous bilateral lesions (arrows) on Ga-68 FAPI-PET, which also identified pathologic lymph nodes (encircled), resulting in upstaging. Image courtesy of the Journal of Nuclear Medicine.
Page 1 of 570
Next Page